PLAY RECORDING

Broadcast Date: Thursday, December 16, 2021
from 12:00 pm to 1:00 pm (ET)

Overview:

The market potential of cannabis has been continuously expanding along with its growing legalization in the US.  With the rise of commercial opportunities, patenting activities in the cannabis industry have also increased, posing new challenges to patent owners and applicants alike. One of the most significant issues surrounding cannabis patent is the assumption that early applicants received an overly broad scope of patents which might affect the industry’s market flow and development in the long run.

While current cases including Canopy Growth Corporation v. GW Pharmaceuticals PLC could provide awareness on the existing regulations for cannabis patent litigation, others believe that will also open additional uncertainties in the wider industry.

Listen as intellectual property lawyers Kevin M. Bell and Matthew D. Zapadka (Arnall Golden Gregory LLP) provide the audience with a comprehensive discussion of the recent developments in cannabis patent litigation. The speakers will also discuss recent notable cases that impact the litigation proceedings

Some of the major topics that will be covered in this course are:

  • Recent Developments in Cannabis Patent Litigation
  • Cannabis Commercialization: Challenges and Pitfalls
  • Canopy Growth Corporation v. GW Pharmaceuticals PLC: Updates
  • Other Notable Cases: Impact on Cannabis Industry
  • An Outlook

Credit:

Advance Preparation:

Print and review course materials

 

Method of Presentation:

On-demand Webcast (CLE)

 

Prerequisite: General knowledge of intellectual property law

 

Course Code:

149762

 

NY Category of CLE Credit:

Areas of Professional Practice

 

Total Credit:

1.0 CLE

Speaker Panel:

Kevin M. Bell, Partner
Arnall Golden Gregory LLP

Kevin Bell is a partner and co-chair of the Intellectual Property practice, a leader of the Patent practice, a member of the Litigation practice, and co-chair of the Dietary Supplements industry team.

Kevin represents U.S. and international companies in biotech, pharmaceutical, medical device, dietary supplement, software, semi-conductor and computer science related matters. He has successfully implemented novel economic theories, resulting in substantial monetary damages awards for his clients at trial. He regularly represents clients before agencies, such as FDA, FTC, DOJ, CBP, National Advertising Division (NAD) of the BBB, and state Attorneys’ General.

Kevin is highly sought after for his success with global strategies to protect and enforce their intellectual property and execute complex, regulatory enforcement efforts in the U.S. and abroad. Kevin has also developed a significant presence in the areas of cannabis and CBDs, as it relates to regulatory, IP and legislative issue.

Matthew D. Zapadka, Of counsel
Arnall Golden Gregory LLP

Matthew D. Zapadka is of counsel in the Intellectual Property practice and a member of the Litigation practice at Arnall Golden Gregory LLP. Matt counsels clients on the protection and enforcement of their intellectual property assets, with a focus on patent litigation. In this role, he advises on various intellectual property disputes in federal district court and state court, as well as trials at the USPTO Patent Trial and Appeal Board (PTAB). Matt has worked with companies, ranging in size from start-ups to Fortune 500, across a variety of sectors, including genetic technologies; biomolecular engineering, such as therapeutic and diagnostic molecules; pharmaceuticals; dietary supplements; cannabis/CBD; nuclear reactors; consumer products; and genetic data visualization systems. Matt is recognized in Best Lawyers: One To Watch in Intellectual Property Law and Super Lawyers’ Rising Star.

Agenda:

Kevin M. BellPartner

Arnall Golden Gregory LLP

AND

Matthew D. ZapadkaOf counsel

Arnall Golden Gregory LLP

  • Overview of important cases in cannabis patent litigation
  • Discussion of procedural and jurisdictional issues and strategy
  • Exploration of technical trends and how those may impact litigation
  • Discussion of unique strategic issues in cannabis patent litigation
  • Damages: from zero to infinity – unique damages consideration in the world of cannabis patent litigation

Materials:

Download Course Materials

Who Should Attend:

  • Patent Lawyers and Consultants
  • Cannabis Law Attorneys
  • Cannabis Business Owners
  • Regulatory and Policy Managers
  • Legal and Compliance Executives
  • Intellectual Property Lawyers and Consultants

SPEAKERS

Kevin M. BellPartner
Arnall Golden Gregory LLP
Matthew D. ZapadkaOf counsel
Arnall Golden Gregory LLP

SUBSCRIPTION PACKAGES

ALL-ACCESS PASS

View Details

CLE LAW MONTHLY

View Details

CPE FINANCE MONTHLY

View Details

Join Over 150,000 Professionals Empowering Their Careers

Learn anywhere from over 1800+ live and recorded CLE CPE & Technology webcasts.